Information for Medical Professionals

Mobile compression devices could reduce thromboembolism rates

Mobile compression devices are as effective as medication at preventing deep vein thromboembolism, it has been claimed.

According to new research published in the Journal of Bone & Joint Surgery, the devices could result in a reduced risk of thromboembolism for patients undergoing total hip replacement surgery.

Orthopaedic surgeon Douglas Padgett, lead author of the new study, said: "This has the potential to change the paradigm as to how we prevent blood clots after hip replacement."

"The efficacy is the same, the safety is markedly better and the cost is comparable," he added.

Researchers looked at the efficacy of the Continuous Enhanced Circulation Therapy Plus Synchronized Flow Technology Compression Device and found that one per cent of patients who used it developed deep vein thrombosis, compared to two per cent in patients receiving blood thinning treatment heparin.

A new trial of Lasofoxifene, found that the drug increased the risk of thromboembolism in postmenopausal women.

---

<< Back

News provided by Adfero in collaboration with Biomet. Please note that all copy is (c) Adfero Ltd and does not reflect the views or opinions of Biomet unless explicitly stated.